Chapter 2 – The Boardroom at Lumière
Milan, Italy – 8:47 AM.
The forty-eighth floor of the Lumière Group headquarters overlooked the city like the command deck of an empire.
Beyond the floor-to-ceiling glass walls, the morning sun spilled across the Gothic spires of Milan Cathedral, illuminating the rooftops and narrow streets below. Inside the executive conference room, however, the atmosphere was anything but peaceful.
A long black marble table stretched across the center of the room. Twelve leather chairs surrounded it, each occupied by a member of the Lumière board or a senior executive. A large digital screen displayed the title of the morning’s meeting:
EMERGENCY PARTNERSHIP REVIEW – MARCUS HOLDINGS / ORGANIC HAIR RESTORATION PROJECT
At the head of the table sat Madame Helen Dubois.
Her silver hair was neatly arranged in its familiar low bun. She wore a cream-colored Chanel-style jacket, a simple pearl necklace, and an expression of absolute composure.
To her right sat two corporate attorneys. To her left was Dr. Antoine Moreau, Lumière’s Global Director of Research and Development, a distinguished chemist with nearly thirty years of experience in cosmetic science.
The remaining seats were occupied by board members, the chief financial officer, and the directors responsible for international acquisitions.
Everyone had been instructed to attend.
No one had been told exactly why.
8:51 AM.
The conference room doors opened.
Marcus entered first.
He wore a perfectly tailored charcoal suit, a blue silk tie, and the confident expression of a man who had spent the previous evening convincing himself that everything could still be repaired.
Lauren followed closely behind him, carrying a slim leather portfolio.
She wore a cream-colored business dress, diamond earrings, and an expensive handbag that Marcus had purchased for her only two weeks earlier.
But the moment Marcus saw Helen sitting at the head of the table, his confident expression faltered.
“Madame Dubois.”
He hurried forward, extending his hand.
“I sincerely apologize for the unfortunate confusion last night. There must have been some misunderstanding regarding the notification we received during the flight.”
Helen glanced at his hand.
She did not take it.
“Please sit down, Mr. Marcus.”
Marcus slowly withdrew his hand.
“Of course.”
He pulled out a chair and sat down.
Lauren settled beside him, placing her portfolio carefully on the table.
Only then did Marcus notice the empty chair directly opposite him.
And the woman standing beside it.
Elena.
She was no longer wearing the drenched burgundy sweater from the previous night.
Instead, she wore a simple ivory blouse beneath a tailored dark-brown blazer, with her chestnut hair tied neatly behind her shoulders.
Her face was pale from the sleepless night, but her eyes were clear.
On the table before her sat a small black leather case.
Marcus stared at her.
Then he let out a short, disbelieving laugh.
“You’re joking.”
Nobody responded.
“Madame Dubois, I hope you don’t intend to turn this important business meeting into a domestic dispute.”
Helen slowly folded her hands.
“Why would you assume that, Mr. Marcus?”
Marcus pointed toward Elena.
“Because she’s my wife. Or, technically, soon to be my ex-wife. Whatever she told you on the airplane, I assure you that she is not qualified to participate in this negotiation.”
Elena remained silent.
Marcus turned toward her.
“And you. I thought I made myself perfectly clear last night. You have no business being here.”
“Neither do you,” Elena replied quietly.
Marcus’s jaw tightened.
“What did you say?”
Elena looked directly at him.
“I said you have no business being here. Not if this meeting is about the ownership of my work.”
Lauren immediately leaned forward.
“Excuse me?”
Helen raised one finger.
“Miss Lauren, I would appreciate it if you allowed everyone to finish speaking before responding.”
Lauren closed her mouth.
Marcus leaned back and forced a smile.
“Madame Dubois, perhaps we should establish the facts before proceeding. I understand that Elena has presented herself as the original creator of our organic hair restoration technology.”
“That is correct,” Helen answered.
Marcus shook his head.
“Then I am afraid you’ve been misinformed.”
He opened his briefcase and removed a thick blue folder.
“The technology belongs to Marcus Holdings. The research was conducted by our product development department, financed by our company, and supervised by our executive team. Elena was merely a technical support employee who assisted with preliminary documentation.”
Elena slowly raised her eyes.
“Technical support?”
Marcus ignored her.
“Our actual lead researcher is Miss Lauren Bennett.”
Lauren sat straighter.
Marcus placed his hand gently over hers.
“She has been directly involved in the formulation process for the past four months. She understands the technology, the manufacturing requirements, and the commercial applications far better than Elena ever did.”
A few board members exchanged glances.
Dr. Moreau adjusted his glasses.
“Four months?”
Marcus nodded.
“Precisely.”
Dr. Moreau looked at Lauren.
“Miss Bennett, how long have you been working with the botanical extraction process?”
Lauren smiled.
“Since I joined the company.”
“Four months ago?”
“Yes.”
“And you claim to have developed the entire formula during that period?”
Lauren hesitated for a fraction of a second.
Marcus answered for her.
“Under my direct supervision, naturally.”
Dr. Moreau slowly removed his glasses.
“Interesting.”
9:03 AM.
Helen turned toward her chief legal counsel.
“Mr. Laurent, please display the first document.”
A large screen illuminated the far wall.
A scanned laboratory notebook appeared.
The first page showed a handwritten formula, dated March 14, three years earlier.
At the bottom was a signature.
ELENA VANCE.
Marcus barely glanced at it.
“That’s an internal laboratory notebook. Anyone could have written that.”
Helen nodded.
“Indeed. Which is why we have additional evidence.”
The screen changed.
This time, it displayed a series of laboratory photographs.
Elena stood beside a glass extraction apparatus, wearing a white laboratory coat. Her hair was tied back, and several handwritten notes were visible on a clipboard.
The photographs were dated across three consecutive years.
Marcus’s expression remained stiff.
“Photographs prove nothing. She worked in our company. Naturally, she would appear in our laboratory.”
Elena finally spoke.
“Then perhaps you can explain why every single photograph was taken before Lauren even joined your company.”
Marcus turned sharply.
“Don’t interrupt.”
“Why?” Elena asked. “Are you afraid someone might ask you a question you cannot answer?”
A faint murmur moved around the table.
Marcus leaned forward.
“Watch your tone.”
Helen’s voice cut through the room.
“Mr. Marcus.”
He turned.
“Yes?”
“Your tone is not the issue here. The evidence is.”
Helen gestured toward the screen.
“Continue.”
9:09 AM.
The second document appeared.
It was an email dated twenty-nine months earlier.
The recipient was Marcus.
The sender was Elena.
The subject line read:
Final stabilization results – Organic Hair Restoration Formula.
The message contained detailed laboratory findings, extraction ratios, pH stability measurements, and a warning about the degradation of one botanical compound under prolonged heat exposure.
At the bottom was Marcus’s reply.
Excellent work. Keep refining the process. We will discuss commercial ownership once the pilot batch is complete.
Elena looked at him.
“Do you remember that email?”
Marcus glanced at the screen.
“I receive hundreds of emails every day.”
“You replied to that one within seven minutes.”
“That doesn’t prove anything.”
“You wrote that the process needed another six months of testing. You told me the company would protect my intellectual property.”
Marcus scoffed.
“Elena, you were my wife. We were building a business together. Don’t pretend every conversation we had was some kind of legal contract.”
Elena’s expression hardened.
“No. But the laboratory records are.”
Lauren suddenly opened her portfolio.
“May I clarify something?”
Helen nodded.
Lauren stood.
“Madame Dubois, the documents Miss Vance is showing you are preliminary research. She may have conducted some early experiments, but the final commercial formula was substantially modified by me.”
Dr. Moreau raised an eyebrow.
“Substantially modified?”
“Yes.”
“Can you identify the three most significant modifications?”
Lauren nodded quickly.
“Of course.”
She opened a printed report.
“The final formula uses a proprietary combination of rosemary extract, argan oil, and a stabilized organic peptide complex. We improved absorption, increased follicular penetration, and reduced oxidation.”
Dr. Moreau looked down at the document.
“Which peptide complex?”
Lauren blinked.
“The organic peptide complex.”
“That is a category, Miss Bennett. I am asking about the specific compound.”
Lauren glanced at Marcus.
He gave her a subtle nod.
“Peptide R-17.”
Dr. Moreau became very still.
“R-17?”
“Yes.”
The scientist placed his glasses back on the table.
“Who identified that compound?”
Lauren swallowed.
“I did.”
“Really?”
“Yes.”
Dr. Moreau turned toward Elena.
“Miss Vance, do you know what R-17 refers to?”
Elena nodded.
“Yes. It was the internal designation for a peptide candidate we abandoned during the second year of development.”
“Why?”
“Because it became unstable when combined with the rosemary extract at temperatures above thirty-eight degrees Celsius. It also caused irritation in repeated patch tests.”
Dr. Moreau slowly turned back toward Lauren.
“Miss Bennett, if R-17 is part of your final commercial formula, how did you solve the stability issue?”
Lauren’s lips parted.
“I… we developed a new stabilization method.”
“Which method?”
“An encapsulation process.”
“What kind of encapsulation?”
Lauren looked at Marcus.
He intervened immediately.
“Dr. Moreau, I don’t think we need to get lost in technical terminology. The commercial formula has already passed our internal quality assessments.”
Dr. Moreau did not look at him.
“I am the Global Director of Research and Development at Lumière. Technical terminology is precisely what I am here for.”
A board member at the far end of the table cleared his throat.
Marcus forced a smile.
“Of course.”
But his fingers had begun tapping nervously against the marble.
9:17 AM.
Helen looked toward Elena.
“Would you like to answer the question?”
Elena opened the black leather case.
Inside were three small glass vials, each containing a different shade of golden liquid.
She placed them on the table.
“The stabilization process was not encapsulation.”
She took out a laboratory report.
“It was a controlled enzymatic conversion process using a naturally derived carrier compound. We discovered that the peptide instability was not caused by the extraction temperature alone. The problem was an interaction between the rosemary polyphenols and the peptide’s terminal amino group.”
Dr. Moreau leaned forward.
“Go on.”
Elena continued.
“By adjusting the extraction sequence and introducing the carrier compound only after the cooling stage, we reduced the degradation rate by more than eighty percent. We also eliminated the irritation response in our final patch tests.”
The room fell quiet.
Dr. Moreau looked at her with growing interest.
“What was the carrier compound?”
Elena opened another folder.
“An enzyme-derived polysaccharide extracted from fermented oat bran.”
Dr. Moreau stared at her.
For several seconds, he said nothing.
Then he looked at the third vial.
“May I?”
Elena pushed it toward him.
He carefully examined the liquid under the conference room’s overhead lighting.
“Is this the final formulation?”
“Yes.”
Dr. Moreau turned toward Helen.
“Madame Dubois, I would strongly recommend that we have this sample independently analyzed before proceeding.”
Marcus abruptly stood.
“Absolutely not!”
Several people turned.
He realized his outburst and lowered his voice.
“I mean, with all due respect, we cannot allow an unauthorized individual to introduce unverified samples into a confidential acquisition meeting.”
Elena looked up.
“Unauthorized?”
Marcus pointed at her.
“Yes. You are no longer representing Marcus Holdings. You have no authority to bring company materials into this room.”
Elena’s eyes narrowed.
“Then perhaps you should explain why you brought my samples to Milan last night.”
Marcus froze.
Lauren’s face lost some of its color.
Elena continued.
“The samples you took from me at the airport. The original glass vials. The ones I labeled and sealed personally.”
Marcus clenched his jaw.
“Those are company property.”
“Then show us the ownership records.”
“I don’t need to explain my company’s internal inventory to you.”
“Of course you don’t,” Elena said. “Because the inventory records are in my handwriting.”
A board member quietly leaned toward another.
Helen watched Marcus without moving.
9:24 AM.
The chairman’s legal counsel placed a new document on the screen.
It was a patent filing.
The filing date was two years and eleven months earlier.
The registered inventor was Elena Vance.
The applicant was listed as an independent research entity.
Marcus’s face changed.
“What is this?”
Helen answered.
“A patent application filed by Miss Vance before the commercial project was transferred to Marcus Holdings.”
Marcus shook his head.
“That’s impossible. The company owns the formula.”
“Do you have a countervailing registration?”
“Of course we do.”
“Then please provide it.”
Marcus opened his briefcase again.
He removed another folder and placed it on the table.
“Here.”
Helen handed it to the legal counsel.
The lawyer studied the document.
His eyebrows rose slightly.
“Mr. Marcus, this assignment agreement appears to transfer ownership of the formula from Elena Vance to Marcus Holdings.”
“Exactly.”
“May I ask when this agreement was executed?”
“Two years ago.”
“Was Miss Vance present when it was signed?”
“Yes.”
Elena stared at him.
“No, I wasn’t.”
Marcus slammed his palm against the table.
“Don’t lie!”
The room erupted in overlapping voices.
“Please!”
“One at a time!”
“Mr. Marcus, control yourself!”
Helen struck the table once with her pen.
Silence returned.
Elena did not raise her voice.
“Show them the signature.”
The lawyer enlarged the document.
At the bottom was Elena’s name.
A signature that looked remarkably similar to hers.
Marcus smiled.
“There’s your proof.”
Elena stared at the screen.
Then she slowly turned toward him.
“That signature is forged.”
Marcus laughed.
“Of course. Now it’s forged.”
“Look at the date.”
“What about it?”
“Look at the date, Marcus.”
The lawyer zoomed in.
September 18.
Elena spoke quietly.
“On September 18, I was in Switzerland attending the European Botanical Chemistry Symposium. I was there for four days. My passport records, hotel registration, and conference attendance records can prove it.”
Marcus’s smile began to disappear.
She continued.
“And there’s something else.”
She pointed at the document.
“The agreement states that I transferred the formula under my married name, Elena Marcus.”
A pause.
“I have never used that name professionally. Not once.”
Dr. Moreau leaned closer.
The lawyer checked the signature block.
He looked at Marcus.
“Mr. Marcus, did your legal department prepare this document?”
Marcus hesitated.
“It was prepared by our corporate counsel.”
“Who witnessed the signature?”
“One of our senior administrators.”
“Name?”
Marcus looked toward Lauren.
She looked down.
The lawyer waited.
Marcus finally answered.
“Richard Cole.”
The legal counsel made a note.
“Mr. Cole is currently employed by your company?”
“Yes.”
“Then I suggest that we request his testimony.”
Marcus’s face tightened.
“That won’t be necessary.”
“Why not?”
“Because I can explain the document.”
Elena leaned forward.
“No. You can explain why you forged it.”
Marcus’s chair scraped backward.
“ENOUGH!”
9:31 AM.
The shout reverberated against the glass walls.
For a moment, the entire boardroom was motionless.
Marcus pointed at Elena.
“You have spent three years benefiting from my name, my money, and my company. You lived in my house. You drove my car. You wore clothes purchased with my salary. And now you sit here pretending that you’re some kind of independent genius?”
Elena’s expression remained unreadable.
Marcus continued.
“Who paid for your laboratory equipment? Who paid the salaries of your assistants? Who provided the facilities? Without Marcus Holdings, you would still be some obscure woman mixing herbs in glass bottles!”
Elena looked down at the table.
Then she smiled.
It was a small, almost sorrowful smile.
“That’s interesting.”
Marcus frowned.
“What?”
“You just said your company paid for everything.”
“Because it did!”
Elena opened another folder.
“Then let’s examine the financial records.”
She distributed several printed pages to the board members.
“The first laboratory equipment purchase was made on April 12, three years ago. The payment came from an account ending in 4821.”
Marcus glanced at the page.
“That’s a company account.”
“No.”
Elena lifted her eyes.
“That’s my personal research account.”
A murmur swept through the room.
Marcus grabbed one of the documents.
“What nonsense is this?”
Elena continued.
“The first extraction apparatus cost $38,600. The chromatography equipment cost another $21,400. The initial botanical materials were purchased from suppliers in France, Switzerland, and Japan. Every invoice was paid using funds I accumulated from my previous research consultancy.”
She paused.
“I also paid the first two laboratory assistants from that account.”
Dr. Moreau looked at the financial statements.
“Is this independently verified?”
“Yes,” Elena answered. “The statements were certified by my bank and my former accountant.”
Marcus threw the document down.
“Even if you paid for some equipment, that doesn’t mean you own the company.”
“No,” Elena replied. “It means your claim that you financed the research is false.”
She leaned slightly forward.
“And it means you have spent three years telling everyone that you built something you never bothered to understand.”
A board member named Victor Rossi removed his glasses.
“Mr. Marcus, is there any explanation for these transactions?”
Marcus turned toward him.
“Victor, this is a personal matter.”
Rossi frowned.
“We are discussing a fifteen-million-dollar investment. It ceased being personal the moment you submitted the proposal.”
Another director joined in.
“If these financial records are accurate, why was the research expenditure declared under Marcus Holdings?”
Marcus’s mouth tightened.
“Because the company commercialized the product.”
“That was not the question.”
“I said we commercialized it!”
“With whose permission?”
Marcus looked around the table.
Nobody came to his rescue.
9:38 AM.
Lauren suddenly stood.
“May I speak?”
Helen nodded.
Lauren straightened her dress.
“I think everyone is overlooking the most important point. Regardless of who conducted the preliminary research, the commercial success of a product depends on more than an original formula.”
She placed a glossy presentation on the table.
“The final product concept, branding, market positioning, packaging strategy, and international launch campaign were developed under my supervision.”
She clicked a remote.
A slide appeared.
LUMIÈRE ORGANIC HAIR RESTORATION – THE FUTURE OF BOTANICAL BEAUTY.
Beneath the title was a photograph of a luxurious amber glass bottle.
Lauren smiled.
“I personally developed the commercial presentation. I also created the product identity that will allow this technology to enter the European luxury market.”
Dr. Moreau looked at the slide.
“Who designed the packaging?”
“Our marketing department.”
“Who selected the botanical ingredients?”
“Our product development team.”
“Who performed the clinical stability testing?”
“Our laboratory.”
“And who is listed as the inventor?”
Lauren hesitated.
“That is an administrative matter.”
Dr. Moreau turned toward her.
“No, Miss Bennett. It is not.”
Lauren’s smile stiffened.
Helen intervened.
“Miss Bennett, I have one question.”
“Yes, Madame Dubois.”
“Have you ever personally conducted a laboratory experiment involving this formula?”
Lauren blinked.
“Of course.”
“Which laboratory?”
“Our main research facility.”
“Which room?”
Lauren looked at Marcus.
“Room 308.”
Dr. Moreau slowly shook his head.
“There is no laboratory room 308 in your company’s research facility.”
Lauren’s face went blank.
Dr. Moreau continued.
“Room 308 is an administrative office. The laboratory rooms are numbered 301, 302, 304, and 305.”
Marcus immediately stood.
“That’s enough. This meeting is becoming absurd.”
Helen looked at him.
“Sit down.”
He hesitated.
“Madame Dubois—”
“Sit. Down.”
Marcus slowly lowered himself into his chair.
Dr. Moreau turned back toward Lauren.
“Miss Bennett, I am going to ask you one final question. When you say you personally developed the final formula, are you claiming that you conducted the laboratory work yourself, or are you claiming that you supervised the work of other scientists?”
Lauren’s fingers tightened around the edge of her portfolio.
“I supervised the team.”
“Which team?”
“The product development team.”
“Names, please.”
Lauren opened her mouth.
Nothing came out.
Elena watched her quietly.
Then she spoke.
“Would you like me to name them?”
Lauren turned sharply.
“Nobody asked you!”
“I know all of them,” Elena replied. “I trained four of them. Two left after Marcus stopped paying their salaries. One was transferred to the manufacturing division. The last one resigned after discovering that his laboratory reports had been submitted under your name.”
Lauren’s face turned red.
“That’s a lie!”
Elena looked at her.
“Then let’s call him.”
9:46 AM.
Helen turned toward her legal counsel.
“Mr. Laurent, did we receive the witness confirmation?”
The lawyer nodded.
“Yes, Madame Dubois.”
Marcus immediately looked up.
“What witness?”
Helen did not answer him.
The conference room doors opened.
A man in his early forties entered.
He wore a simple navy suit, carried a leather document case, and appeared deeply uncomfortable under the attention of so many senior executives.
Elena recognized him immediately.
“Daniel.”
The man gave her a small nod.
Marcus went pale.
“Daniel Hayes?”
Lauren whispered something under her breath.
Daniel walked toward the table.
“Good morning.”
Helen gestured toward the empty chair.
“Please introduce yourself.”
“My name is Daniel Hayes. I was the senior laboratory technician at Marcus Holdings for three years. I worked directly under Elena Vance on the organic hair restoration project.”
Marcus leaned forward.
“Daniel, I don’t know who contacted you, but this is a confidential corporate meeting.”
Daniel placed his document case on the table.
“I know.”
“Then you understand that disclosing company information could expose you to legal action.”
Daniel looked at him.
“Mr. Marcus, you stopped paying my salary six months ago. You also terminated my employment without paying the outstanding research compensation.”
Marcus’s jaw tightened.
“That is a separate matter.”
“Is it?”
Daniel opened the case.
“Because I have something that may interest everyone here.”
He removed a small external storage device and handed it to the legal counsel.
“These are the original laboratory logs, raw test results, and electronic revision histories from the project.”
Marcus suddenly stood again.
“Those files belong to my company!”
Daniel looked directly at him.
“Then why did you delete them?”
Silence.
The question seemed to suck all the air from the room.
Marcus stared at him.
“What?”
Daniel continued.
“Three weeks ago, the entire original research directory disappeared from the company server. The official explanation was that it had been corrupted during a system migration.”
Lauren looked down.
“But the backup server retained the original files,” Daniel said. “I copied them before my access was terminated.”
The legal counsel connected the storage device to the conference room computer.
A list of folders appeared.
PROJECT E.V. – ORIGINAL RESEARCH
FORMULATION HISTORY
CLINICAL TESTING
AUTHORSHIP RECORDS
INTERNAL COMMUNICATIONS
Dr. Moreau leaned forward.
“Open the formulation history.”
The screen filled with hundreds of timestamped entries.
Every modification had a name attached to it.
Every measurement had a date.
Every experiment had a corresponding laboratory record.
At the top of the list was one recurring name.
ELENA VANCE.
Daniel pointed toward the screen.
“Miss Vance created the original formula. I assisted with the extraction tests. The other scientists handled stability analysis, quality control, and pilot production.”
He paused.
“Lauren Bennett never conducted a single experiment.”
Lauren shot to her feet.
“That’s outrageous!”
Daniel looked at her.
“You came into the laboratory twice.”
“That’s not true!”
“Once to take photographs for the company’s promotional materials. The second time to ask Elena for the formula so you could prepare your presentation.”
Lauren’s voice rose.
“You’re a disgruntled former employee! You’re trying to destroy my career because you were fired!”
Daniel remained calm.
“I expected you to say that.”
He opened another folder.
“That’s why I brought the original access logs.”
The screen changed.
A record showed Lauren’s company account accessing the research directory.
The date was four months earlier.
The activity log displayed a series of downloaded files.
Elena’s original laboratory notebooks.
Her final formula.
Her stability reports.
Her clinical testing results.
Every file had been copied to a personal external drive.
The destination account was registered under Lauren Bennett.
Marcus’s face had turned ashen.
Lauren whispered:
“That doesn’t prove anything.”
Daniel looked at her.
“It proves you downloaded the entire research archive three days before submitting your so-called original formulation to the executive committee.”
9:54 AM.
The room erupted.
“Is this accurate?”
“Who authorized the access?”
“Mr. Marcus, did you know about this?”
“Madame Dubois, we need to suspend the meeting!”
Helen raised her hand.
“One at a time.”
The voices gradually died away.
Helen looked at Lauren.
“Miss Bennett, do you deny downloading those files?”
Lauren’s lips trembled.
“I was preparing a presentation.”
“Did you tell the board that you had personally developed the formula?”
“I…”
“Yes or no?”
Lauren glanced at Marcus.
He stared straight ahead.
For the first time since entering the building, he did not offer her a reassuring smile.
Lauren swallowed.
“I was presenting the work on behalf of the company.”
Helen’s expression remained unchanged.
“That was not my question.”
Lauren lowered her eyes.
“No.”
Marcus abruptly turned toward her.
“Lauren.”
She looked at him.
He spoke through clenched teeth.
“Be careful.”
But something had changed.
The woman who had entered the room confidently believing she would become Product Development Director was now sitting beneath the weight of her own lies.
Elena watched her.
There was no triumph in her expression.
Only exhaustion.
10:02 AM.
Helen leaned back.
“Mr. Marcus, I believe we have established that Miss Vance created the formula, that Miss Bennett downloaded the original research files, and that your company submitted a commercial proposal without properly identifying the inventor.”
Marcus rubbed his forehead.
“Madame Dubois, I admit there may have been some administrative irregularities.”
“Administrative irregularities?”
“We can resolve them privately. Elena and I are still legally married. There are personal arrangements that can be made.”
Elena stared at him.
“Personal arrangements?”
Marcus turned toward her.
“Elena, listen. We’ve both made mistakes. We don’t need to destroy everything over this.”
She said nothing.
He continued, lowering his voice.
“I can make things right. I’ll give you the Product Development Director position. We’ll renegotiate your compensation. You can even have a percentage of the contract.”
Elena looked at him for several seconds.
Then she asked:
“How much?”
Marcus blinked.
“What?”
“How much of my own work are you offering to give back to me?”
He swallowed.
“Thirty percent.”
A short, bitter laugh escaped her.
“Three years of research. Thousands of hours. Every sleepless night. Every failed experiment. Every dollar I spent building the technology that you just tried to steal.”
She leaned forward.
“And you’re offering me thirty percent?”
Marcus lowered his voice.
“Don’t make this worse than it needs to be.”
Elena’s eyes hardened.
“You left me standing in the rain with divorce papers in my hand. You called me a wet rat in front of your mistress. You took the samples from my hands and told me to go home.”
She paused.
“And now you want to negotiate?”
Marcus looked around the room.
Nobody moved.
He turned back toward her.
“Elena, I was under pressure.”
“No. You were under the impression that I would never fight back.”
For the first time, Marcus had no answer.
Helen slowly closed the folder before her.
“Mr. Marcus, I believe this meeting has reached its conclusion.”
Marcus immediately stood.
“Wait.”
Helen looked at him.
“Is there something else?”
“Yes. I would like to speak with you privately.”
“About what?”
“The investment.”
Helen studied him.
Then she shook her head.
“There will be no investment in Marcus Holdings.”
Marcus’s face crumpled.
“Madame Dubois, please. We have existing commitments. We have suppliers, employees, and outstanding loans.”
“Then you should have considered those responsibilities before attempting to misappropriate another person’s intellectual property.”
“But the company will collapse!”
Helen’s voice remained quiet.
“That is a matter for your shareholders and creditors.”
Marcus turned toward Elena.
“Tell her to reconsider!”
Elena did not move.
“Elena!”
He walked around the table.
“You know what happens if this company collapses. You worked there. You know how many people depend on us!”
Elena finally stood.
“Don’t you dare use those employees as a shield.”
Marcus stopped.
“You used the company to humiliate me, to steal my work, and to build a future with another woman. If you cared about your employees, you would never have put their livelihoods at risk for your own greed.”
His face twisted.
“You think you’re better than me now?”
“No,” Elena answered.
She picked up her black leather case.
“I think I’m finally done being smaller than you.”
10:11 AM.
Helen was about to signal the meeting’s adjournment when the conference room’s telephone rang.
The chief legal counsel picked it up.
“Yes?”
He listened.
His expression gradually changed.
“Are you certain?”
Another pause.
“Send the document to this room immediately.”
He hung up.
Helen noticed his expression.
“What is it?”
The lawyer hesitated.
“Madame, the external patent counsel has just completed the preliminary verification of Miss Vance’s original filing.”
“And?”
“The patent application is not the only relevant registration.”
He looked toward Elena.
“There’s an additional ownership record.”
Marcus frowned.
“What ownership record?”
The lawyer turned toward the computer.
“Three years ago, before Marcus Holdings entered the commercial development agreement, Miss Vance registered the original formula and its associated manufacturing process through a private research holding company.”
Elena’s face changed.
She slowly sat back down.
Marcus stared at her.
“What’s he talking about?”
The lawyer continued.
“The holding company is called Vance Botanical Technologies.”
A pause.
“The sole shareholder is Elena Vance.”
Marcus laughed nervously.
“So? She registered a company. What does that have to do with anything?”
The lawyer opened the document.
“Under the commercial development agreement, Marcus Holdings was granted a limited manufacturing and distribution license. It was not granted ownership of the underlying formula.”
Dr. Moreau leaned forward.
“Show us the licensing terms.”
The document appeared on the screen.
Helen read it carefully.
Then her eyes narrowed.
“Clause fourteen.”
The lawyer enlarged the relevant section.
It stated that the license would automatically terminate upon any unauthorized transfer, misrepresentation of inventorship, or attempted assignment of intellectual property to a third party.
Marcus stared at the words.
“No.”
The lawyer continued.
“Furthermore, the agreement contains a reversion clause. Upon termination, all manufacturing rights, sublicensing permissions, and access to proprietary technical documentation revert immediately to Vance Botanical Technologies.”
Marcus’s lips parted.
“But we have been manufacturing the product.”
“Under license,” the lawyer corrected.
“Those facilities are ours!”
“The facilities may be yours, Mr. Marcus. The intellectual property is not.”
Lauren slowly turned toward Marcus.
“Marcus…”
He ignored her.
“Who drafted this agreement?”
The lawyer answered.
“Your former corporate legal department.”
“Who approved it?”
“Your board of directors.”
“Who signed it?”
The lawyer looked down.
Then he looked up.
“You did, Mr. Marcus.”
The room went completely silent.
Marcus stared at the signature on the screen.
His own signature.
Three years earlier, he had signed the agreement believing it was merely an administrative formality that would allow his company to commercialize Elena’s research.
He had never bothered to read the termination provisions.
Elena looked at him.
“Do you remember what you told me when I asked you to protect my research?”
Marcus did not answer.
“You said I didn’t understand business. You said I should leave the contracts to you.”
Her voice remained steady.
“So I did.”
She opened her black leather case and removed one final document.
“I let you negotiate the licensing agreement. I let your lawyers review it. I even let you choose the commercial structure.”
She placed the document in front of him.
“Because I trusted you.”
Marcus looked down.
At the bottom of the document was a second signature.
ELENA VANCE – FOUNDER AND SOLE SHAREHOLDER, VANCE BOTANICAL TECHNOLOGIES.
He looked up.
“What do you want?”
Elena did not answer immediately.
Helen studied her carefully.
Then Elena spoke.
“I want my research returned. I want the unauthorized use of my formula stopped. I want an independent audit of every product sold under that license. And I want the employees who worked on this project to receive the compensation they were promised.”
Marcus shook his head.
“You can’t do this.”
“I can.”
“You’ll destroy everything!”
“No, Marcus.”
She looked directly into his eyes.
“You already did that.”
10:19 AM.
The conference room doors opened once more.
A young legal assistant entered carrying a sealed envelope.
She approached Helen and whispered something.
Helen opened the envelope.
Inside was a formal notice bearing the seal of the Milan Chamber of Commerce and a separate certification from the European patent counsel.
She read the first page.
Then she stopped.
For the first time that morning, the expression on her face changed.
Not anger.
Not satisfaction.
Surprise.
Deep, unmistakable surprise.
Dr. Moreau noticed immediately.
“Madame Dubois?”
Helen slowly looked toward Elena.
“Miss Vance.”
“Yes?”
“May I ask you something?”
“Of course.”
Helen held up the document.
“Are you aware that Vance Botanical Technologies has been listed as the original rights holder for the entire botanical restoration platform, including the second-generation follicular regeneration process?”
Elena frowned.
“Yes. That’s part of the original registration.”
Helen shook her head slightly.
“No, I don’t think you understand what I am asking.”
She placed the document on the table.
“The patent counsel has identified a second international registration, filed through your company eight months ago. It covers a process that has not yet been commercially disclosed.”
Dr. Moreau leaned forward.
“Which process?”
Helen looked at him.
“The next-generation cellular repair technology.”
The scientist’s face went pale.
“That’s impossible.”
He quickly took the document.
His eyes moved across the technical description.
Then he looked at Elena.
“Miss Vance… did you develop this?”
Elena nodded slowly.
“It was an extension of the original botanical platform. We were testing it before I left the laboratory.”
Dr. Moreau stared at the document.
“Do you understand what this could mean?”
Elena shook her head.
“I know what the early results showed. But the clinical trials were not complete.”
Dr. Moreau looked at Helen.
“Madame, this changes the entire valuation.”
Marcus was no longer listening.
He was staring at the screen.
At the top of the document, beneath the registration number, was a heading he had never seen before.
INTERNATIONAL EXCLUSIVE DEVELOPMENT RIGHTS – VANCE BOTANICAL TECHNOLOGIES.
And beneath it was a list of companies that had already expressed interest.
Lumière Cosmetics Group.
A Swiss pharmaceutical consortium.
Two major Japanese beauty manufacturers.
And one final name.
Marcus leaned closer.
His breath caught.
MARCUS HOLDINGS.
He looked at Elena.
“What is that?”
Elena’s expression changed.
She had not expected to see that name either.
Helen turned toward the legal counsel.
“Explain.”
The lawyer carefully examined the final page.
“It appears Marcus Holdings submitted an application for a secondary development partnership six weeks ago.”
Marcus shook his head.
“I don’t know anything about that.”
The lawyer continued reading.
“The application was submitted through an intermediary corporation. The declared beneficial owner is not Marcus Holdings.”
Marcus’s eyes widened.
“Who?”
The lawyer turned the document around.
At the bottom was the name of the controlling entity.
LAUREN BENNETT.
Nobody spoke.
Lauren went completely still.
Marcus slowly turned toward her.
“Lauren?”
She did not answer.
He looked back at the document.
“How?”
Lauren’s hands began trembling.
“Marcus, I can explain.”
He stared at her.
“You registered a company?”
“It wasn’t what you think.”
“Using my company’s name?”
“I was protecting myself!”
Marcus’s face twisted.
“Protecting yourself from what?”
Lauren suddenly raised her voice.
“From you!”
The words exploded across the conference room.
Marcus froze.
Lauren stood, tears gathering in her eyes.
“You promised me I would become Director of Product Development! You promised that once the contract was signed, we would build our own company and leave everything behind!”
Marcus stared at her.
“You said the formula belonged to us!”
“It was supposed to!”
“You told me Elena had no legal rights!”
“You told me your lawyers had taken care of everything!”
The board members watched in stunned silence as the two people who had entered the room together began turning against each other.
Lauren pointed at Marcus.
“You were the one who told me to download the research files! You were the one who said Elena would never discover what we were doing!”
Marcus’s face turned crimson.
“Shut your mouth!”
“No! I’m done protecting you!”
Helen slowly placed both hands on the table.
“Miss Bennett.”
Lauren turned toward her.
“Yes?”
“Who owns the intermediary corporation?”
Lauren hesitated.
Then she whispered:
“I do.”
“And who authorized the use of the proprietary research files?”
Lauren looked at Marcus.
He was staring at her with undisguised hatred.
She swallowed.
“Mr. Marcus.”
The room fell silent again.
Helen turned toward her legal counsel.
“Please preserve every document, electronic record, and communication related to this matter. I want an independent forensic audit initiated immediately.”
The lawyer nodded.
“Understood.”
Marcus sank into his chair.
Lauren sat down slowly.
Neither looked at the other.
At the far end of the table, Dr. Moreau was still studying the second-generation patent registration.
Finally, he looked up.
“Madame Dubois.”
Helen turned.
“Yes?”
“I believe we have been negotiating with the wrong company.”
Helen looked toward Elena.
A faint smile appeared on her face.
“I believe you’re right.”
She turned to the entire board.
“Ladies and gentlemen, I would like to amend the agenda.”
The digital screen went dark.
A new title appeared.
STRATEGIC ACQUISITION AND GLOBAL PARTNERSHIP – VANCE BOTANICAL TECHNOLOGIES.
Elena stared at it.
“Madame Helen…”
Helen gently interrupted her.
“Miss Vance, I made a mistake when I first reviewed this project. I believed I was evaluating an interesting formula developed by a small company.”
She paused.
“Now I realize I may have been evaluating the beginning of an entirely new industry.”
Marcus slowly lifted his head.
“Madame Dubois, please. We can still reach an agreement. Marcus Holdings has the manufacturing infrastructure. We have distribution networks. We have the personnel.”
Helen looked at him.
“Mr. Marcus, you have one thing I am no longer interested in.”
“What?”
“An opportunity to explain why we should trust you.”
She turned toward Elena.
“Miss Vance, would you consider becoming Lumière’s exclusive research partner?”
Elena looked at the documents before her.
Three years of work.
Three years of sacrifice.
Three years of believing that the man she loved would eventually recognize what she had built.
And now, in a room filled with the most powerful executives in the European cosmetics industry, the decision was finally hers.
She took a slow breath.
“Before I answer, I have one condition.”
Helen nodded.
“Name it.”
Elena looked toward Daniel.
Then toward the other members of the original research team whose names appeared in the laboratory records.
“I will not build another company where the people who create the work are invisible while someone else takes the credit.”
Dr. Moreau slowly smiled.
Helen’s expression softened.
“Then I believe we understand each other.”
But before anyone could respond, the conference room telephone rang again.
The chief legal counsel answered.
“Yes?”
His expression changed.
He listened for several seconds.
Then he looked toward Helen.
“Madame, the Milan financial authorities have just contacted our compliance department.”
Helen frowned.
“Why?”
The lawyer hesitated.
“They have received a formal complaint concerning the transfer of funds from Marcus Holdings to an offshore account.”
Marcus immediately stood.
“What?”
The lawyer looked at the report.
“The complaint was filed last night.”
Marcus’s face turned pale.
“By whom?”
The lawyer slowly turned the document over.
At the bottom was a name.
RICHARD COLE.
The same senior administrator Marcus had identified as the witness to Elena’s supposedly forged assignment agreement.
Helen looked at Marcus.
“Mr. Marcus.”
Marcus stood motionless.
“Who is Richard Cole?”
Marcus opened his mouth.
But no sound came out.
Then Elena quietly spoke.
“He’s not just the man who witnessed the signature.”
Everyone turned toward her.
She looked at the document in the lawyer’s hand.
“He’s the person who helped Marcus create the original formula’s false ownership records.”
A long silence followed.
Helen’s expression became serious.
“How do you know that?”
Elena slowly opened her black leather case.
From beneath the original laboratory notebooks, she removed a small silver USB drive.
“I found something in my old research archive three months ago. I wasn’t sure what it meant at the time.”
She placed it in the center of the table.
“But I think we’re about to find out.”
Marcus stared at the device.
His face had become almost colorless.
“Elena…”
She did not look at him.
Helen turned toward the legal counsel.
“Connect it.”
The screen flickered.
A single video file appeared.
SEPTEMBER_18_OWNERSHIP_TRANSFER_FINAL.mp4
The date of the allegedly forged agreement.
The lawyer clicked.
The video began.
And the moment the first voice emerged from the speakers, Marcus’s entire body went rigid.
It was his own voice.
“Just make sure Elena’s signature looks authentic. Once the Lumière contract is signed, nobody will ever bother checking the original paperwork.”
A second voice followed.
A voice that everyone in the room recognized.
Richard Cole.
“And what if she finds out?”
Marcus’s recorded voice answered without hesitation.
“By then, she’ll be divorced, the company will own the product, and she’ll have nothing left to fight for.”
The recording continued.
Then came a third voice.
A woman’s voice.
Lauren’s.
“And my name? You promised my name would be on the patent.”
Marcus laughed in the recording.
“Of course, sweetheart. You’re going to be the face of the entire project.”
The video stopped.
Nobody moved.
Nobody spoke.
Not even the air-conditioning seemed audible anymore.
Marcus looked at Lauren.
Lauren looked at Marcus.
And across the table, Elena slowly closed her leather case.
Helen Dubois removed her glasses.
She looked at Marcus with an expression colder than anything Elena had seen that morning.
“Mr. Marcus.”
He did not answer.
“Do you have anything to say before I ask our legal department to refer this recording to the appropriate authorities?”
Marcus’s lips trembled.
“That’s… that’s been taken out of context.”
Helen stared at him.
“Which part?”
He swallowed.
“The recording.”
“Your voice?”
Marcus said nothing.
“Your instructions?”
Still nothing.
“Or the fact that you planned to deprive your wife of her intellectual property before you even filed for divorce?”
Marcus slowly lowered his eyes.
For the first time in three years, he had nothing left to hide behind.
And for the first time in three years, Elena Vance did not have to defend herself.
The evidence was speaking for her.
10:34 AM.
Helen turned toward Elena.
“Miss Vance, I believe we should discuss your future partnership.”
Elena looked through the floor-to-ceiling windows.
Far below, Milan continued its morning routine. Cars moved through the streets. Office workers hurried across the sidewalks. The city seemed entirely unaware that an empire had just begun to crumble on the forty-eighth floor.
She looked back at Helen.
“Yes, Madame. I believe we should.”
Then she glanced once at Marcus.
Not with hatred.
Not with regret.
But with the calm expression of someone who had finally closed a door that should have been shut a long time ago.
The woman he had left standing in the rain had just walked into the most powerful boardroom in Europe—and the man who had taken her name, her work, and her dignity was now the only person in the room with nothing left to offer.
⚑ Report